BioMed Realty uses cookies to compile aggregate data about website traffic and interactions so that we can offer a better site experience and content in the future. We use third party companies such as Google Analytics to assist us in understanding our website visitors. Read more about our terms & privacy policy, E.U.-U.S. Privacy Shield Policy, and UK Modern Slavery Act Transparency Statement 2018.

Skip to main navigationSkip to main contentSkip to footer

Center for Novel Therapeutics

9310 Athena Circle
La Jolla, CA 92037


BioMed Realty in partnership with the University of California San Diego launched a new initiative by way of the Center for Novel Therapeutics (CNT) to facilitate the transition of research from the laboratory into the clinic and from the campus to the marketplace.

CNT is a unique San Diego region facility dedicated to experimental therapeutics located on the 32 acre Science Research Park campus. CNT is equally divided among academic and industry tenants, with generous space for shared resources such as conference center, administrative suite and core facilities; it contains high technology translational research and core laboratories, to study under one roof products discovered and developed through emerging academic/industry partnerships. The fitness center and café will only enhance the opportunities for collaboration and sharing. Clinical testing will be performed via multiple settings in San Diego including the UC San Diego Altman Clinical and Translational Research Institute, Moores Cancer Center and UC San Diego Jacobs Medical Center. The Center for Novel Therapeutics is LEED® Gold Certified.

Key Amenities

  • Conference Center - provides a variety of space needs from all-hands to break-out sessions
  • Atrium - the heart of the building providing a place for impromptu gatherings as well as event space for corporate functions
  • Restaurant - Locally sourced farm to table
  • Modern fitness center

Click here to read the latest news for CNT.

Square Footage137,568
Number of Buildings1

Center for Novel Therapeutics